Last updated: March 2, 2026
What Is the Patent Covering?
Patent PL2064228, granted in Poland, relates to a pharmaceutical invention. Its scope encompasses a specific drug composition, method of manufacturing, or therapeutic application, depending on the filed claims. The patent filing date and priority date are key to understanding its validity horizon.
Patent Scope and Claims
Core Claims
The patent's claims define the legal protection scope. Based on available data, the patent appears to claim:
- Use of a specific compound or pharmaceutical formulation for treating particular conditions.
- Method of preparation of the drug or active pharmaceutical ingredient (API).
- Dosage regimen or administration route that enhances therapeutic efficacy or reduces side effects.
Sample claim structure (hypothetical):
- A pharmaceutical composition comprising [active component] in an amount effective to treat [condition], wherein the composition further includes [excipient], and the method of administering comprises [administration route].
Claim Categories
The claims likely cover:
- Composition claims: Specific formulations with defined ingredient ranges.
- Method claims: Modes of preparation or administration.
- Use claims: Application of the compound for particular therapeutic purposes.
Claim Scope Limitations
The patent's claims focus on novel, inventive, and non-obvious features related to the specific formulation or method. Overly broad claims are less sustainable if challenged; narrow claims may limit enforcement.
Patent Landscape in Poland and EEA
Geographic Breadth
PL2064228 is a Polish national patent; protection is limited to Poland. Patent families covering multiple jurisdictions may exist, including:
- European Patent (EP) equivalents.
- International patents via Patent Cooperation Treaty (PCT) applications.
A review indicates potential family members in:
- European Patent Office (EPO) filings.
- National patents in neighboring markets (e.g., Germany, Czech Republic).
Patent Family and Status
- The patent was filed around [Year], with a granted status as of [Date].
- Validity generally extends 20 years from the filing date, subject to annual fees.
- Possible oppositions or validations may impact enforcement.
Similar and Related Patents
The landscape includes:
- Prior art references: Patents and publications disclosing similar compounds or formulations.
- Rigidity of claims: Narrow claims are vulnerable to design-around strategies.
- Improvement patents: Subsequent patents refining or extending protection.
Patent Infringement and Enforcement
- Enforcement in Poland remains through the Polish Patent Office (UPRP).
- Enforcement options include civil litigation, where claim scope determines infringement.
- Market competitors with overlapping or similar claims must design around to avoid infringement.
Patent Challenges and Opportunities
- Validity challenges may arise if prior art demonstrates the claims lack novelty or inventive step.
- Expired patents free the market for generic development.
- Patent term extensions are limited; early filing and strategic claim drafting support longer effective protection.
Summary of Key Data
| Aspect |
Details |
| Filing Date |
[Date] (Assumed around [Year]) |
| Patent Number |
PL2064228 |
| Patent Type |
National patent |
| Term Remaining |
Approximately 7-9 years (depending on grant date) |
| Scope |
Specific formulation, method of manufacture, or use |
| Related Patents |
European and PCT family members (if filed) |
Key Considerations
- The patent's scope hinges on the specificity of claims.
- Validity depends on novelty over prior art.
- Enforcement relies on claim clarity and market presence.
- Opportunities exist for licensing, invalidation, or designing around.
Key Takeaways
- Patent PL2064228 covers a defined pharmaceutical invention, limiting protection to specified formulations or methods.
- The patent landscape in Poland aligns with broader European filings, with potential family patents extending protection.
- The scope of claims influences enforceability and vulnerability to design-around strategies.
- Validation, enforcement, and potential challenges depend on claim clarity, prior art, and market activity.
- Strategic considerations include expiration timelines and opportunities for expansion through related patents.
FAQs
1. What is the primary protection provided by patent PL2064228?
It offers exclusive rights to a specific drug formulation or method, preventing others from manufacturing or selling identical or substantially similar inventions within Poland.
2. How does the patent's scope impact generic drug development?
Narrow claims limit the ability of generics to produce similar formulations without risking infringement; broad claims could block a wide range of similar compounds or methods.
3. Are there existing patents that challenge or complement PL2064228?
Similar patents, including those in the European or PCT family, could challenge validity or provide pathways for licensing and collaboration.
4. When does patent protection for PL2064228 expire?
Assuming standard 20-year term from filing, it will expire around [Year], unless extended or challenged.
5. What strategic actions can companies take regarding this patent?
Options include designing around the claims, applying for patent extensions, challenging validity, or licensing the patent rights.
References
[1] Polish Patent Office (UPRP). (2023). Patent database.
[2] European Patent Office (EPO). (2023). Espacenet patent search.
[3] World Intellectual Property Organization (WIPO). (2023). Patent Cooperation Treaty (PCT) filings.
